Various membrane ATPases have been tested for their sensitivity to baflomycin Al, a macrolide antibiotic. F1Fo ATPases from bacteria and mitochondria are not affected by this antibiotic. In contrast, ElE2 ATPases-e.g., the K+-dependent (Kdp) ATPase from Escherichia coli, the Na4+,K+ -ATPase from ox brain, and the Ca2+-ATPase from sarcoplasmic reticulum-are moderately sensitive to this inhibitor. Finally, membrane ATPases from Neurospora vacuoles, chromaffin granules, and plant vacuoles are extremely sensitive. and, in the case of the Na4 ,K4-ATPase, by ouabain (5-11).
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From this we conclude that bafilomycin Al is a valuable tool for distinguishing among the three different types of ATPases and represents the first relatively specific potent inhibitor of vacuolar ATPases.
In both prokaryotic and eukaryotic organisms most ionpumping ATPases that have been characterized fit into one of three structural types.t (i) The F1Fo ATPases (F-type) have been found in the inner mitochondrial membrane (2) , the thylakoid membrane of chloroplasts (3) , and the bacterial cytoplasmic membrane (4) . (ii) The E1E2 ATPases (P-type) are present in the cell plasma membranes of fungi (5) , plants (6) , and animals [including the Na',K4-ATPase (7) and the H + ,K + -ATPase (8) ], as well as in the sarcoplasmic reticulum of muscle cells (Ca2+-ATPase) (9) and the bacterial cytoplasmic membrane (K+-ATPase) (10, 11) . (iii) A third class of ATPases (V-type) has been identified and partially purified from membranes of fungal and plant vacuoles (ref. 12 and refs. therein), of coated vesicles (13, 14) , and of chromaffin granules (15, 16) . As suggested by Mellman et al. (17) , we use the term "vacuolar ATPases" to refer to this third group. The F1Fo ATPases typically use the electrochemical gradient of H+ (18) or occasionally a Na+ gradient (19) to synthesize ATP. This type of enzyme also exhibits ATPase activity, in some cases only after activation with proteases (20) . The enzymatic activity of F1Fo ATPases is inhibited by azide and N,N'-dicyclohexylcarbodiimide; the mitochondrial ATPase is inhibited by oligomycin as well (21) .
In the E1E2 ATPases the energy released by the hydrolysis of ATP is coupled to the translocation of cations across the membrane. The enzyme cycles through conformational states including the formation of a phosphorylated intermediate. The enzymatic activity is not affected by azide or oligomycin but is specifically inhibited by vanadate, in most cases by N-ethylmaleimide and fluorescein isothiocyanate, and, in the case of the Na4 ,K4-ATPase, by ouabain (5-11).
The vacuolar ATPases appear to hydrolyze ATP, generating a proton gradient that is used for acidification of compartments within cells (12, 17, 22) . This group of ATPases has been distinguished from the other two by virtue of its inhibitor specificity. The vacuolar ATPases are not inhibited by azide, oligomycin, vanadate, or ouabain. Instead, inhibitors that have proved useful for these enzymes include (i) N,N'-dicyclohexylcarbodiimide, which also inhibits F1F0 and E1E2 ATPases, (ii) N-ethylmaleimide, which inhibits E1E2 enzymes (23) and at least one F1F0 ATPase (24) , and (iii) NO3 -, which is effective only at millimolar concentrations or greater. Thus, no potent specific inhibitor of vacuolar ATPases has yet been identified.
The bafilomycins A1, B1, C1, and D, macrolide antibiotics with a 16-membered lactone ring, were isolated from Streptomyces sp. (25) . These compounds inhibited growth of Gram-positive bacteria and fungi in a disc diffusion assay. In addition, it has been reported that bafilomycin C1 inhibits the enzymatic activity of the Na4,K4-ATPase (26, 27) . In this communication, we compare the effects of bafilomycin A1 on representative enzymes of the three classes of ATPases. The results show that bafilomycin A1 is useful for distinguishing among the different types of ATPases and that it is an extremely potent inhibitor of the vacuolar ATPases.
MATERIALS AND METHODS
Preparative Procedures. The preparation of the ATP synthase from Escherichia coli KY 7485 was as described (28, 29) . The K4-dependent (Kdp)-ATPase from E. coli strain TK2240-40 was prepared as described (30) . Preparation of plasma membranes, mitochondria, vacuolar membranes (31), solubilized vacuolar ATPase (32) , and purified plasma membrane ATPase (33) from Neurospora crassa was as described. Purified Na4,K4-ATPase from ox brain (34) was a gift from W. Schoner (University of Giessen, F.R.G.). Bovine chromaffin granule membranes were provided by D. K. Apps (University of Edinburgh, Scotland). Sarcoplasmic reticulum vesicles (Ca2+-ATPase) from rabbit muscle were a gift from G. Blickenstaff (Tufts University, Boston). Plant vacuolar membranes were provided by L. Taiz (University of California, Santa Cruz, CA).
Assays. The following procedures have been described: assays for ATPase activity of the E. coli F1F0 and the Kdp-ATPase (30, 35) , for the plasma membrane ATPase, the mitochondrial F1F0 ATPase, and the vacuolar ATPase of N.
crassa (31) , for the plant vacuolar ATPase (36) , for the Ca2+-ATPase (37), and for the Na4,K4-ATPase (ref. 38 , using the assay buffer described in ref. 39 ). To assay the chromaffin granule ATPase, we used the procedure for the N. crassa vacuolar ATPase. Stock solutions of bafilomycins were prepared in dimethyl sulfoxide and stored at -20'C. The actual concentrations of the stock solutions were determined spectrophotometrically using the molar extinction coefficients published in ref. 25 . The final concentration of dimethyl sulfoxide in the assay Abbreviation: Kdp-ATPase, K+-dependent ATPase. tWe follow the classical nomenclature; the more recently proposed categorization by Pedersen and Carafoli (1) is indicated in parentheses.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. mixture did not exceed 1%, and control samples without bafilomycin contained dimethyl sulfoxide. Bafilomycin A1 was present in the assay mixtures at the concentrations given in the figures; the incubation volume was 0.5 ml throughout. Protein was determined as described in ref. 40 or 41. H + translocation by the vacuolar ATPase ofN. crassa was monitored by the fluorescence quenching of quinacrine in a 2-ml volume containing 0.01 mM quinacrine, 1 mM MgSO4, 0.1 mM Na3VO4, 100 mM KCI, bafilomycin Al (as indicated in Fig. 4 ), vacuolar membrane vesicles (-30 gg of protein), and 25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid NaOH buffer (pH 7.5). The reaction was initiated with the addition of 1 mM Na2ATP (pH was adjusted to 7.5 with Tris base) and the reaction was reversed with 2.5 IxM nigericin. Quinacrine fluorescence was measured with excitation and emission wavelengths of 420 and 496 nm, respectively.
Materials. The bafilomycins were gifts from H. Zahner (University of Jubingen, F.R.G.) and Bayer (Wuppertal, F.R.G.). Quinacrine and nigericin were purchased from Sigma.
RESULTS
When different types of membrane ATPases were treated with bafilomycin Al, whose structure is shown in Fig. 1 (Fig. 2) .
Similar results were obtained with the ATP synthase from mitochondria (N. crassa; Table 1 ).
By contrast, ATPases of the E1E2 type, the Na',K+-ATPase from ox brain (Fig. 2) , and the Ca2+-ATPase from sarcoplasmic reticulum (Table 1) H'-pumping activity of the vacuolar ATPase of N. crassa.
As shown in Fig. 4 , H + translocation was completely inhibited by 10 nM bafilomycin Al. Again, the I value deduced from this experiment was very low, -0.74 x 1i0
Amol/mg. We could not perform a similar experiment in E. Al are not common to all polyene antibiotics. For instance, nystatin (at concentrations up to 10 tLM) had no effect on any of the three ATPases from Neurospora. Inhibition by bafilomycin, which we have been unable to reverse, was not competitive with ATP. Finally, bafilomycin'was unable to prevent labeling of the 151kDa polypeptide of the vacuolar ATPase by radiolabeled N,N'-dicyclohexylcarbodiimide.
With the exception of the substitution at C-21, the structures of bafilomycins Al, B1, and C1 are identical (Fig. 1) .
Compared with these three compounds, bafilomycin D has a quite different side chain at position C-15 of the macrolide ring. These variabilities in structure and hydrophobicity result in different inhibitory effects with the Kdp-ATPase from E. coli (unpublished results). The three Neurospora ATPases, in their membrane-bound forms, proved about equally sensitive to bafilomycins B1, C1, or D as to bafilomycin A1. Whether the effect observed with the Kdp-ATPase is particular for this enzyme or dependent on the specific lipid environment must be determined. In this paper, we identify the first inhibitor that may be able to fulfill these roles for the vacuolar ATPases. Vacuolar ATPases from a fungus (N. crassa), a plant (Z. mays), and an animal (bovine adrenal medulla) proved exquisitely sensitive to bafilomycin A1 at concentrations <1O' ,umol/mg. Because we now know that vacuolar ATPases are homologous to F1F0 ATPases (52, 53) , it is interesting that bafilomycin Al is not effective against the E. coli membrane or Neurospora mitochondrial ATPase. This observation further implies that the effect of bafilomycin Al is highly specific for the class of vacuolar enzymes.
DISCUSSION
Although several assumptions are involved in the calculations (see Results), it appears highly probable that bafilomycin Al interacts stoichiometrically at least with the Neurospora vacuolar ATPase. Thus, ifa stable labeled form of the inhibitor can be produced and if it proves to bind covalently, a number of experiments on enzyme mechanism become feasible. Based on the broad range of organisms affected by bafilomycin A1, it is likely to prove useful in the characterization and purification of further vacuolar ATPases. In addition, bafilomycin Al represents the first good opportunity for selecting mutants of the vacuolar ATPase in N. crassa (and other organisms). We have obtained mutant strains of N. crassa, whose growth is resistant to bafilomycin Al.
The effect of bafilomycin Al on E1E2 ATPases is more difficult to evaluate. Our interest in the compounds began with the finding that micromolar concentrations of bafilomycins Al, B1, C1, and Dwere all good inhibitors of the KdpATPase of E. coli and that the bafilomycins affected enzyme activity differentially in accordance with variabilities in the structure of the antibiotic. We also observed that bafilomycin A1 was a moderately good inhibitor (1-4 umol/mg) of two other E1E2 ATPases, the Na',K+-ATPase and the Ca2+-ATPase.
The effect of bafilomycin on E1E2 ATPases is not universal, however. The plasma membrane ATPase of N. crassa, which belongs to this family on the basis of its structure, vanadate sensitivity, and sequence homology, but differs from the other members of this class in that it appears to pump only protons (5), was considerably less sensitive (150, 100 ,umol/mg) to bafilomycin A1. Similarly, in S. faecalis, Solioz and colleagues (11, 54) have identified and characterized an ATPase consisting of a single polypeptide. This ATPase forms an aspartyl-phosphate intermediate and is inhibited by micromolar concentrations of vanadate (55) . Based on these properties this ATPase represents the simplest E1E2 ATPase described to date, and it is insensitive to bafilomycin A1 at concentrations up to 1 mM (30 ,umol/mg). We conclude that the bafilomycins show promise for probing the structure of the Kdp-ATPase and may prove useful for other E1E2 ATPases as well. As a relatively specific inhibitor of high potency, bafilomycin Al and its relatives appear excellent candidates for probing the structure and function of the least understood category of membrane ATPases, the vacuolar ATPases.
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